Our executive leadership team enjoys more than 100 years of joint industry experience. ABEX’s organisational structure is flat and empowered which ensures quick and effective communication and decision making, allowing us every competitive advantage in bringing new products to market as quickly and safely as possible with a fast and effective support to our selected partners.
ABEX owns and manages a strong portfolio of registered prescription medicines which we commercialise with attractive and flexible business models on a business to business (B2B) basis, offering our partners novel product opportunities and excellent market access potential. We have also established a well-recognised portfolio of branded Consumer Health products marketed and distributed under the ABEX umbrella, including several international brands.
Our experienced technical and regulatory team take care of all forms of dossier preparations and submissions, as well as offering complete peace of mind across the product value chain from IP protection to life-cycle management and pharmacovigilance solutions.
Based on the excellent dossiers and high quality standards of our competitively positioned portfolio, ABEX has successfully developed a growing international footprint in most regulated markets, including the UK, Europe, Australia, New Zealand and Pacific rim area as well as the Middle East and more recently, various LATAM countries.